flumazenil has been researched along with cgp 35348 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bowery, N; Castro, AR; Castro-Lopes, JM | 1 |
| Carter, LP; Coop, A; France, CP; Koek, W; Wu, H | 1 |
2 other study(ies) available for flumazenil and cgp 35348
| Article | Year |
|---|---|
Baclofen and midazolam alter c-fos induction by peripheral noxious or innocuous stimulation in the spinal cord of normal and monoarthritic rats.
Topics: Animals; Arthritis, Experimental; Baclofen; Flumazenil; GABA Agonists; GABA Antagonists; GABA Modulators; Genes, fos; Male; Midazolam; Organophosphorus Compounds; Physical Stimulation; Rats; Rats, Wistar; Spinal Cord; Stimulation, Chemical | 1999 |
Discriminative stimulus effects of flumazenil: perceptual masking by baclofen, and lack of substitution with gamma-hydroxybutyrate and its precursors 1,4-butanediol and gamma-butyrolactone.
Topics: 4-Butyrolactone; Animals; Baclofen; Benzocycloheptenes; Butylene Glycols; Columbidae; Discrimination, Psychological; Dose-Response Relationship, Drug; Flumazenil; GABA Agonists; GABA Antagonists; GABA Modulators; GABA-A Receptor Agonists; GABA-A Receptor Antagonists; GABA-B Receptor Agonists; GABA-B Receptor Antagonists; Organophosphorus Compounds; Sodium Oxybate | 2006 |